Literature DB >> 2572996

Excitatory amino acid receptor-mediated activation of solitarial deglutitive loci.

M A Hashim1, D Bieger.   

Abstract

The deglutitive actions of glutamate were investigated in urethane-anaesthetised rats in order to determine whether different excitatory amino acid receptors mediate activation of pattern generator elements contained within the nucleus tractus solitarii. When applied by micropneumophoresis (0.01-10 pmol) from multibarrelled glass micropipettes (tip diameter 2-5 microns), the excitatory amino acid-receptor agonists, N-methyl-D, L-aspartate (NMA), N-methyl-D-aspartate (NMDA), quisqualate and kainate displayed a rank order of potency at glutamate-responsive pharyngeal sites, in the subnuclei ventralis and intermedialis, where KA greater than NMA/NMDA greater than QA; however, the potency followed the order NMA/NMDA greater than KA greater than QA at oesophageal sites within the subnucleus centralis. The NMDA-receptor blockers, 2-amino-5-phosphonovaleric acid (APV) and 2-amino-7-phosphonoheptanoic acid (AP7), selectively and reversibly inhibited the glutamate-evoked oesophageal responses, but had no corresponding effect on rhythmic oesophageal responses elicited by muscarine. At loci in the nucleus tractus solitarius, where glutamate elicited a complete swallowing sequence, APV/AP7 spared the pharyngeal component but selectively blocked the oesophageal component. The nonselective glutamate-receptor antagonist, gamma-D-glutamylglycine suppressed both pharyngeal and oesophageal responses elicited by glutamate. It is concluded that different types of excitatory amino acid receptors are associated with the deglutitive premotor subnuclei of the nucleus tractus solitarii; kainate receptors predominate within the subnuclei ventralis and intermedialis and NMDA receptors within the subnucleus centralis. Both kainate- and NMDA-mediated mechanisms can operate under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572996     DOI: 10.1016/0028-3908(89)90190-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

Review 1.  Neuropharmacologic correlates of deglutition: lessons from fictive swallowing.

Authors:  D Bieger
Journal:  Dysphagia       Date:  1991       Impact factor: 3.438

Review 2.  Brain stem control of the phases of swallowing.

Authors:  Ivan M Lang
Journal:  Dysphagia       Date:  2009-04-28       Impact factor: 3.438

Review 3.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

4.  Is glutamate involved in transient lower esophageal sphincter relaxations?

Authors:  D P Hirsch; G N J Tytgat; G E E Boeckxstaens
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

5.  Central nervous system control mechanisms of swallowing: a neuropharmacological perspective.

Authors:  D Bieger
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 6.  The search for the central swallowing pathway: the quest for clarity.

Authors:  A J Miller
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 7.  The brainstem esophagomotor network pattern generator: a rodent model.

Authors:  D Bieger
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

8.  Swallowing responses induced by microinjection of glutamate and glutamate agonists into the nucleus tractus solitarius of ketamine-anesthetized rats.

Authors:  J P Kessler; N Cherkaoui; D Catalin; A Jean
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

9.  Distribution of aspartate and glutamate in the nucleus of the solitary tract of the lamb.

Authors:  R D Sweazey
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

10.  Cannabinoids facilitate the swallowing reflex elicited by the superior laryngeal nerve stimulation in rats.

Authors:  Rahman Md Mostafeezur; Hossain Md Zakir; Hanako Takatsuji; Yoshiaki Yamada; Kensuke Yamamura; Junichi Kitagawa
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.